Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Current Drug Targets
|
December 6, 2001
Pharmacology of appetite suppression: implication for the treatment of obesity
J C Halford
Pharmacology, Biochemistry, and Behavior
|
August 1, 1996
Metergoline antagonizes fluoxetine-induced suppression of food intake but not changes in the behavioural satiety sequence
J C Halford, J E Blundell
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
September 1, 1995
Pharmacological aspects of obesity treatment: towards the 21st century
J E Blundell, J C Halford
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques
|
June 17, 2000
Pharmacology of appetite suppression
J C Halford, J E Blundell
Annals of Medicine
|
May 23, 2000
Separate systems for serotonin and leptin in appetite control
J C Halford, J E Blundell
Physiology & Behavior
|
September 1, 1996
The 5-HT1B receptor agonist CP-94,253 reduces food intake and preserves the behavioural satiety sequence
J C Halford, J E Blundell
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
July 24, 2001
Regulation of appetite: role of leptin in signalling systems for drive and satiety
J E Blundell, S Goodson, J C Halford
The International Journal of Eating Disorders
|
May 9, 2000
Developmental onset of eating-related color-naming interference: the role of restraint and eating psychopathology
P J Lattimore, G M Thompson, J C Halford
Obesity Research
|
November 1, 1995
Serotonin, eating behavior, and fat intake
J E Blundell, C L Lawton, J C Halford
Pharmacology, Biochemistry, and Behavior
|
January 1, 1997
The 5-HT2 receptor agonist MK-212 reduces food intake and increases resting but prevents the behavioural satiety sequence
J C Halford, C L Lawton, J E Blundell
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Current Drug Targets
|
December 6, 2001
Pharmacology of appetite suppression: implication for the treatment of obesity
J C Halford
Pharmacology, Biochemistry, and Behavior
|
August 1, 1996
Metergoline antagonizes fluoxetine-induced suppression of food intake but not changes in the behavioural satiety sequence
J C Halford, J E Blundell
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
September 1, 1995
Pharmacological aspects of obesity treatment: towards the 21st century
J E Blundell, J C Halford
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques
|
June 17, 2000
Pharmacology of appetite suppression
J C Halford, J E Blundell
Annals of Medicine
|
May 23, 2000
Separate systems for serotonin and leptin in appetite control
J C Halford, J E Blundell
Physiology & Behavior
|
September 1, 1996
The 5-HT1B receptor agonist CP-94,253 reduces food intake and preserves the behavioural satiety sequence
J C Halford, J E Blundell
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
July 24, 2001
Regulation of appetite: role of leptin in signalling systems for drive and satiety
J E Blundell, S Goodson, J C Halford
The International Journal of Eating Disorders
|
May 9, 2000
Developmental onset of eating-related color-naming interference: the role of restraint and eating psychopathology
P J Lattimore, G M Thompson, J C Halford
Obesity Research
|
November 1, 1995
Serotonin, eating behavior, and fat intake
J E Blundell, C L Lawton, J C Halford
Pharmacology, Biochemistry, and Behavior
|
January 1, 1997
The 5-HT2 receptor agonist MK-212 reduces food intake and increases resting but prevents the behavioural satiety sequence
J C Halford, C L Lawton, J E Blundell
Page
of 2